Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.

Identifieur interne : 000275 ( PubMed/Curation ); précédent : 000274; suivant : 000276

Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.

Auteurs : Rory D. De Vries [Pays-Bas] ; Sander Herfst [Pays-Bas] ; Mathilde Richard [Pays-Bas]

Source :

RBID : pubmed:30044370

Abstract

Influenza A viruses can infect a wide range of hosts, creating opportunities for zoonotic transmission, i.e., transmission from animals to humans, and placing the human population at constant risk of potential pandemics. In the last hundred years, four influenza A virus pandemics have had a devastating effect, especially the 1918 influenza pandemic that took the lives of at least 40 million people. There is a constant risk that currently circulating avian influenza A viruses (e.g., H5N1, H7N9) will cause a new pandemic. Vaccines are the cornerstone in preparing for and combating potential pandemics. Despite exceptional advances in the design and development of (pre-)pandemic vaccines, there are still serious challenges to overcome, mainly caused by intrinsic characteristics of influenza A viruses: Rapid evolution and a broad host range combined with maintenance in animal reservoirs, making it near impossible to predict the nature and source of the next pandemic virus. Here, recent advances in the development of vaccination strategies to prepare against a pandemic virus coming from the avian reservoir will be discussed. Furthermore, remaining challenges will be addressed, setting the agenda for future research in the development of new vaccination strategies against potentially pandemic influenza A viruses.

DOI: 10.3390/vaccines6030046
PubMed: 30044370

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:30044370

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.</title>
<author>
<name sortKey="De Vries, Rory D" sort="De Vries, Rory D" uniqKey="De Vries R" first="Rory D" last="De Vries">Rory D. De Vries</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. r.d.devries@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Herfst, Sander" sort="Herfst, Sander" uniqKey="Herfst S" first="Sander" last="Herfst">Sander Herfst</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. s.herfst@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Richard, Mathilde" sort="Richard, Mathilde" uniqKey="Richard M" first="Mathilde" last="Richard">Mathilde Richard</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. m.richard@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30044370</idno>
<idno type="pmid">30044370</idno>
<idno type="doi">10.3390/vaccines6030046</idno>
<idno type="wicri:Area/PubMed/Corpus">000275</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000275</idno>
<idno type="wicri:Area/PubMed/Curation">000275</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000275</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.</title>
<author>
<name sortKey="De Vries, Rory D" sort="De Vries, Rory D" uniqKey="De Vries R" first="Rory D" last="De Vries">Rory D. De Vries</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. r.d.devries@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Herfst, Sander" sort="Herfst, Sander" uniqKey="Herfst S" first="Sander" last="Herfst">Sander Herfst</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. s.herfst@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Richard, Mathilde" sort="Richard, Mathilde" uniqKey="Richard M" first="Mathilde" last="Richard">Mathilde Richard</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. m.richard@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Vaccines</title>
<idno type="ISSN">2076-393X</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Influenza A viruses can infect a wide range of hosts, creating opportunities for zoonotic transmission, i.e., transmission from animals to humans, and placing the human population at constant risk of potential pandemics. In the last hundred years, four influenza A virus pandemics have had a devastating effect, especially the 1918 influenza pandemic that took the lives of at least 40 million people. There is a constant risk that currently circulating avian influenza A viruses (e.g., H5N1, H7N9) will cause a new pandemic. Vaccines are the cornerstone in preparing for and combating potential pandemics. Despite exceptional advances in the design and development of (pre-)pandemic vaccines, there are still serious challenges to overcome, mainly caused by intrinsic characteristics of influenza A viruses: Rapid evolution and a broad host range combined with maintenance in animal reservoirs, making it near impossible to predict the nature and source of the next pandemic virus. Here, recent advances in the development of vaccination strategies to prepare against a pandemic virus coming from the avian reservoir will be discussed. Furthermore, remaining challenges will be addressed, setting the agenda for future research in the development of new vaccination strategies against potentially pandemic influenza A viruses.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">30044370</PMID>
<DateRevised>
<Year>2019</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">2076-393X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2018</Year>
<Month>Jul</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>Vaccines</Title>
<ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation>
</Journal>
<ArticleTitle>Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E46</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines6030046</ELocationID>
<Abstract>
<AbstractText>Influenza A viruses can infect a wide range of hosts, creating opportunities for zoonotic transmission, i.e., transmission from animals to humans, and placing the human population at constant risk of potential pandemics. In the last hundred years, four influenza A virus pandemics have had a devastating effect, especially the 1918 influenza pandemic that took the lives of at least 40 million people. There is a constant risk that currently circulating avian influenza A viruses (e.g., H5N1, H7N9) will cause a new pandemic. Vaccines are the cornerstone in preparing for and combating potential pandemics. Despite exceptional advances in the design and development of (pre-)pandemic vaccines, there are still serious challenges to overcome, mainly caused by intrinsic characteristics of influenza A viruses: Rapid evolution and a broad host range combined with maintenance in animal reservoirs, making it near impossible to predict the nature and source of the next pandemic virus. Here, recent advances in the development of vaccination strategies to prepare against a pandemic virus coming from the avian reservoir will be discussed. Furthermore, remaining challenges will be addressed, setting the agenda for future research in the development of new vaccination strategies against potentially pandemic influenza A viruses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>de Vries</LastName>
<ForeName>Rory D</ForeName>
<Initials>RD</Initials>
<Identifier Source="ORCID">0000-0003-2817-0127</Identifier>
<AffiliationInfo>
<Affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. r.d.devries@erasmusmc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herfst</LastName>
<ForeName>Sander</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0001-9866-8903</Identifier>
<AffiliationInfo>
<Affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. s.herfst@erasmusmc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richard</LastName>
<ForeName>Mathilde</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Viroscience, Erasmus MC, P.O. Box 2040, 3000CA Rotterdam, The Netherlands. m.richard@erasmusmc.nl.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>07</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Vaccines (Basel)</MedlineTA>
<NlmUniqueID>101629355</NlmUniqueID>
<ISSNLinking>2076-393X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">avian influenza A virus</Keyword>
<Keyword MajorTopicYN="N">pandemic</Keyword>
<Keyword MajorTopicYN="N">vaccination</Keyword>
<Keyword MajorTopicYN="N">zoonosis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>06</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>07</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>07</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>7</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>7</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>7</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30044370</ArticleId>
<ArticleId IdType="pii">vaccines6030046</ArticleId>
<ArticleId IdType="doi">10.3390/vaccines6030046</ArticleId>
<ArticleId IdType="pmc">PMC6161001</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>PLoS Med. 2006 Sep;3(9):e360</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16968127</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2014 Nov 21;346(6212):996-1000</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25414313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2014 Jul 17;6(7):2735-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25036462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Med Virol. 2012 Jul;22(4):267-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22438243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Apr 20;25(16):2984-2989</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17306909</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Mar 1;182(5):3063-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19234203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Oct 15;194(8):1040-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16991078</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Dec 13;362(9400):1959-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14683655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2016 May;492:197-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26967975</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2014 Apr 10;157(2):329-339</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24725402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Virol. 2013 Oct;3(5):521-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23978327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Jun;82(11):5161-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18353950</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2001 Jun 16;357(9272):1937-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11425416</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(10):e26335</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22039464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008 Jan 02;3(1):e1401</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18167560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Aug;83(15):7770-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19457991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 May;83(9):4624-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19211745</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008;3(6):e2432</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19293944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Apr 07;6(4):e18577</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21490925</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2015 Oct 20;6(5):e01487-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26489862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2011 Feb 03;342:c7297</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21292718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2016 Feb;126(2):605-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26731473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Mar 18;27(13):1889-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19368768</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Nov 12;9(11):e112302</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25391151</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):349-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21173241</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2011 Feb 11;29(8):1529-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21211583</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2008 Sep 1;198(5):635-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18694338</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2015 Mar 10;6(2):e02556</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25759506</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2014 Mar 14;6(3):1294-316</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24638204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2014 Feb;20(2):143-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24412922</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Oct 23;27(45):6284-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19856521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Nov;88(22):13418-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25210172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2005 Apr 15;191(8):1210-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15776364</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2012 Nov;86(21):11735-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22915811</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Life Sci. 2000 Nov;57(12):1770-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11130181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Vaccines. 2014 Jul;13(7):873-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24855993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19416838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Mar 26;9(3):e92822</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24671139</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2014 Sep;464-465:156-165</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25078114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2008 Jul;14(7):e1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18598616</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2009 Feb 1;199(3):405-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19061423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12915-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16118277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1978 Jun 1;87(1):13-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">664248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Feb;88(3):1684-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24257602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2015 Mar 1;211(5):791-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25246535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2012 Jun 22;336(6088):1534-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22723413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Aug 6;27(36):4953-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19540952</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>One Health. 2015 Dec 1;1:1-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26309905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Vaccines. 2009 Apr;8(4):499-508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19348565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2013 Jan 1;190(1):220-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23225881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Nov;88(22):13300-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25210173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Vaccin Immunother. 2015;11(3):572-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25671661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Oct 15;10(10):e0140702</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26469190</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prev Med. 1974 Mar;3(1):97-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4205586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2015 Mar;14(3):167-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25722244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Mar 16;28(13):2565-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20117262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Jun 18;459(7249):931-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19525932</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2017 Sep 15;216(suppl_4):S555-S559</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28934456</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2013 Nov 22;342(6161):976-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24264991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2017 Nov 14;91(23):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28956760</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2016 Nov;498:36-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27543757</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2014 Jun 10;5(3):e01070-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24917596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Nov;84(22):11822-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20844051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2014 Oct 8;312(14):1409-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25291577</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2015 Mar 16;200:9-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25599603</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2015 Jan 15;33(4):500-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25498210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Dec;80(23):11756-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16971435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 Sep 27;489(7417):526-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22982990</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med Bull. 1979 Jan;35(1):69-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">367490</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Jan;88(1):699-704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24155380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2018 May 14;92(11):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29563296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Dec 17;8(12):e83274</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24358269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Jan 24;6(1):e16247</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21283631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2016 Jun 3;34(26):2926-2933</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27038130</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2017 Aug;17(8):833-842</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28533093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 Jun 15;209(12):1860-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24604819</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2017 Jul;75(1):71-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28390707</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008 Jun 25;3(6):e2517</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18575608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 Jul;7(4):506-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22897930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Jun 24;27(31):4187-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19406182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2011 Jan 15;186(2):1022-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21169548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Jul;84(13):6570-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20427525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 May 02;486(7403):420-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22722205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22371588</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2013 Oct;19(10):1305-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24056771</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2017 Aug;508:164-169</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28554058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18137-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19822741</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2015 Jun;21(6):1086-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25988813</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(12):e50830</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23239987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2014 Dec;14(12):1196-207</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25455987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Vaccin Immunother. 2016 Nov;12(11):2881-2901</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27455345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Future Virol. 2014 May 1;9(5):513-524</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25214882</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Jun 8;27(28):3744-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19464558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2015 Jun 02;6:287</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26082783</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2011 Apr 5;29(16):3043-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21320540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2007 Jun 1;195(11):1598-606</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17471429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2006 Jan;12(1):15-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16494711</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2011 Mar 1;203(5):666-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21282194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2013 Mar;94(Pt 3):583-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23152369</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Nov 12;4(11):e7790</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19915662</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Jul 15;194(2):159-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16779721</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000275 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000275 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:30044370
   |texte=   Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:30044370" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021